Sanjiv KaulM.D.

  • CEO of the Knight Cardiovascular Institute
  • Professor of Medicine, Division of Cardiovascular Medicine, School of Medicine


  • Cardiology

Special focus on

  • Cardiac Imaging
  • General Cardiology
  • Heart Disease and Diabetes

I see patients at


Dr. Kaul has pioneered the field of microbubble echocardiology (myocardial contrast echocardiography), a powerfully effective screening test for the early detection of coronary heart disease. He joined OHSU in 2005 and is the CEO of the Knight Cardiovascular Institute. Dr. Kaul's major clinical and research interest is coronary artery disease.


  • Residency:

    • Internal medicine - University of Vermont, Burlington, Vt.
  • Fellowship:

    • Cardiology - Wadsworth VA Medical Center, UCLA, Los Angeles, Calif.
    • Cardiology - Massachusetts General Hospital, Harvard Medical School, Boston, Mass.
  • Certifications:

    • American Board of Internal Medicine, internal medicine


  • English
  • Hindi
  • Kashmiri
  • Punjabi
  • Urdu

Memberships and associations

  • American Society for Clinical Investigation
  • Association of American Physicians
  • American Clinical and Climatological Association
  • Association of University Cardiologists
  • American College of Cardiology
  • American Heart Association
  • American Society of Echocardiography

Patient ratings

4.8 out of 5 (30 Ratings, 17 Comments)

The patient ratings score is an average of all responses to the question "How likely would you be to recommend this provider to your family and friends (on a scale of 0 to 10)" on our nationally-recognized NRC patient surveys.

  1. {{ item.comments[0]['comment'] }}